Five-year survival rates with neoadjuvant immune checkpoint inhibitors reach up to 87.5% in melanoma patients, especially among those achieving major pathological response.
- Open access
Cutaneous Melanoma Detection and Management
Moving in bioRxiv, Cancer Research, Frontiers in Genetics, medRxiv and Nature Medicine.
- Moved, week to 23 Oct 2026
- 0
- Papers in 60 days
- 5
Add Cutaneous Melanoma Detection and Management as an interest in JClubFree on iPhone and Android · interests shape Home, Discover and your digest
Rebuilt
Moved this week
Nothing in this topic has moved yet this week.
Latest in Cutaneous Melanoma Detection and Management
Newest first · last 60 days
Ultrasound radiomics combined with an immune-related gene signature predicts melanoma response to immune checkpoint inhibitors with 78-88% accuracy.
- Open access
Cost-Aware EfficientNet (CAEN) achieves up to 87% recall in skin lesion classification across diverse skin tones, reducing bias in dermatological AI by 16.75% over previous models.
- Open access
Spatial analysis uncovers that melanoma transition involves a 3-fold increase in proliferation, metabolic changes, and microenvironment remodeling in nevus-associated melanomas.
Add Cutaneous Melanoma Detection and Management as an interest in JClub
Browse JClub
Journals this month
- bioRxiv6157
- medRxiv1716
- PNAS447
- Sci Adv354
- JAMA262
- Environ Res230
- BMJ182
- Environ Pollution165
- Nat Commun161
- Science141
- Nature138
- Lancet128
- Cell Rep120
- NEJM119
- mBio107
- Plant Cell Environ107
- Curr Biol106
- J Exp Bot106
Topics moving, week to 23 Oct 2026
- Single-cell and spatial transcriptomics6
- Neuroinflammation and Neurodegeneration Mechanisms5
- Bacteriophages and microbial interactions5
- Gut microbiota and health5
- Genomics and Phylogenetic Studies4
- Cancer Genomics and Diagnostics4
- Cancer Immunotherapy and Biomarkers4
- Alzheimer's disease research and treatments3
- Inflammatory Bowel Disease3
- Influenza Virus Research Studies3